[The etiotropic and pathogenetic treatment of patients with chronic gastritis and primary chronic gastroduodenitis].
120 patients with chronic gastritis and primary chronic gastroduodenitis were given a three-week course of etiopathogenetic treatment (antichelibacterial and immunocorrective drugs) that allowed to diminish the clinical, bacteriological and immune manifestations of the disease and achieve a complete cure in most patients. Patients with marked chelibacteriosis revealed greater refractoriness. The authors recommend prolonged courses of treatment with alternations of etiologically directed drugs.
Lukash
N V
NV
Buglak
N P
NP
Kriuchkova
O N
ON
Skripka
V I
VI
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000097:blood; D001327:Autoimmune Diseases / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D004382:Duodenitis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005756:Gastritis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D016481:Helicobacter Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D016480:Helicobacter pylori / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged
D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial
Ob étiotropnom i patogeneticheskom lechenii bol'nykh khronicheskim gastritom i pervichnym khronicheskim gastroduodenitom.